Quanterix Corporation Right-of-Use Asset Obtained in Exchange for Operating Lease Liability
Quanterix Corporation (QTRX) reported Right-of-Use Asset Obtained in Exchange for Operating Lease Liability of $6.17 million for the 9-month period ending 2025-09-30, per its 10-Q filed 2025-11-10.
Financial Statements › Notes › Leases
us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability · last filed 2025-11-10
- Quanterix Corporation right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2025-09-30 was $5.63M.
- Quanterix Corporation right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2024-12-31 was $0.00.
- Quanterix Corporation right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2024-09-30 was $0.00.
- Quanterix Corporation right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2022-12-31 was $255.00K.
- Quanterix Corporation right-of-use asset obtained in exchange for operating lease liability for fiscal 2024 was $0.00.
- Quanterix Corporation right-of-use asset obtained in exchange for operating lease liability for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- Quanterix Corporation right-of-use asset obtained in exchange for operating lease liability for fiscal 2022 was $22.49M.
- Quanterix Corporation right-of-use asset obtained in exchange for operating lease liability for fiscal 2021 was $0.00.
| Period end | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 3 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 6 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 9 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 12 month |
|---|---|---|---|---|
| 2025-09-30 | $5.63M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $6.17M 10-Q · filed 2025-11-10 | ||
| 2025-06-30 | $548.00K 10-Q · filed 2025-08-07 | |||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-17 | $0.00 derived: sum of 2 quarters · filed 2025-11-10 | $0.00 10-K · filed 2025-03-17 | |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $0.00 10-Q · filed 2025-11-10 | ||
| 2024-06-30 | $0.00 10-Q · filed 2025-08-07 | |||
| 2023-12-31 | $0.00 10-K · filed 2025-03-17 | |||
| 2022-12-31 | $255.00K derived: 10-K 12 month − 10-K/A 9 month · filed 2025-03-17 | $118.00K derived: sum of 2 quarters · filed 2025-03-17 | $4.34M derived: sum of 3 quarters · filed 2025-03-17 | $22.49M 10-K · filed 2025-03-17 |
| 2022-09-30 | -$137.00K derived: 10-K/A 9 month − 10-Q 6 month · filed 2024-12-26 | $4.08M derived: sum of 2 quarters · filed 2024-12-26 | $22.24M 10-K/A · filed 2024-12-26 | |
| 2022-06-30 | $4.22M derived: 10-Q 6 month − 10-K/A 3 month · filed 2023-08-08 | $22.38M 10-Q · filed 2023-08-08 | ||
| 2022-03-31 | $18.16M 10-K/A · filed 2024-12-26 | |||
| 2021-12-31 | $0.00 10-K/A · filed 2024-12-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |